NL
DE
6 March 2020
In the project, an international consortium comprising researchers from Denmark, Sweden, Germany and The Netherlands, together with a number of companies, will probe new technologies to analyse monosaccharide sequences in heparin/heparan sulfate and apply defined oligosaccharides in the field of regenerative medicine.
In the project, an international consortium comprising researchers from Denmark, Sweden, Germany and The Netherlands, together with a number of companies, will probe new technologies to analyse monosaccharide sequences in heparin/heparan sulfate and apply defined oligosaccharides in the field of regenerative medicine.
-
Want to know more about these subjects? Click on the buttons below for more news.
Related news items
Willeke Daamen ratified as ETRS board member
3 November 2021 Willeke Daamen, theme Reconstructive and regenerative medicine appointed as board member of The European Tissue Repair Society (ETRS). read more
Two grants aiming at cornea regeneration for Jo Huiqing Zhou
10 June 2021 Jo Huiqing Zhou is awarded with the ZonMw Open grant and the Velux Stiftung grant, both aiming at cornea regeneration. read more
Grant for early detection of ovarian cancer
5 June 2020 The Department of Biochemistry (Toin van Kuppevelt/Willeke Daamen), together with the Department of Gynecology, has been awarded a grant of 144 kEuro for the development of an assay for the early detection of ovarian cancer. read more
3 million euro for Marie Curie ITN SkinTERM
5 June 2020 The European Union has provisionally awarded a grant of more than 3 million euro to the SkinTERM project “Skin Tissue Engineering and Regenerative Medicine: From skin repair to regeneration”. SkinTERM is coordinated with Willeke Daamen as coordinator and Toin van Kuppevelt as vice coordinator. read more
Plugging the gap ZonMw/Health Holland grant
3 March 2020 RIMLS en RIHS researchers Willeke Daamen, Frank Vandenbussche, Joris van Drongelen, Toin van Kuppevelt and Janneke Grutters have been granted 1.3 million euro for the development and evaluation of a new technology to prevent premature rupture of fetal membranes (iPPROM). read more
